Teza Capital Management LLC Amylyx Pharmaceuticals, Inc. Transaction History

Teza Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.62 - $2.71 $5,299 - $8,864	-3,271 Reduced 24.35%	10,160 $19,000
Q1 2024 May 15, 2024	SELL	$2.71 - $19.57 $3,330 - $24,051	-1,229 Reduced 8.38%	13,431 $38,000
Q4 2023 Feb 14, 2024	SELL	$12.07 - $18.46 $107,833 - $164,921	-8,934 Reduced 37.87%	14,660 $215,000
Q3 2023 Feb 22, 2024	SELL	$18.08 - $23.45 $51,763 - $67,137	-2,863 Reduced 19.53%	11,797 $216,000
Q3 2023 Nov 14, 2023	BUY	$18.08 - $23.45 $426,579 - $553,279	23,594 New	23,594 $432,000

127

44.4M

235K

530K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $308M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Teza Capital Management LLC with notifications on news.